FRENES
Become a partner

Excipients · 4 min read

Microcrystalline Cellulose: A Cornerstone Excipient for Tablets and Capsules

It never appears on a medicine box, yet it hides inside the vast majority of tablets sold worldwide. Microcrystalline cellulose, or MCC, is the quiet excipient without which many active ingredients would never hold together as a tablet. Here is a look at its history, manufacturing process, and role in pharmaceutical formulation.

Pharmaceutical raw material vials on a tray
Identity card
Name Microcrystalline cellulose (MCC)
Common trade names Avicel®, Vivapur®, Pharmacel®
Molecular formula (C6H10O5)n
Nature Purified, partially depolymerized natural polymer of β-D-glucose
Appearance White, fine, odorless and tasteless powder; insoluble in water
Role Excipient: diluent, binder, disintegrant

A Quiet Excipient, Everywhere in Tablets

Microcrystalline cellulose (often abbreviated MCC) is one of the most widely used excipients worldwide in the manufacture of solid oral dosage forms.

Invisible to the patient, it is nonetheless present in an overwhelming proportion of the tablets and capsules on the market. Its versatility — acting at once as a diluent, binder, and disintegrant — combined with its excellent compressibility, has made it a cornerstone of modern pharmaceutical formulation.

Origin and Discovery

Microcrystalline cellulose is not a new molecule but a purified derivative of cellulose, the most abundant polymer in the plant kingdom and a key component of plant and wood cell walls. Cellulose itself was first identified as early as 1838 by the French chemist Anselme Payen.

Microcrystalline cellulose, by contrast, is a mid-20th-century innovation. It was developed in the 1950s by researcher Orlando A. Battista and his collaborator Patricia Smith at the American Viscose Corporation (later part of the FMC group). The product was launched commercially in the early 1960s under the now-iconic Avicel brand, which remains a reference name in the pharmaceutical and food industries today.

Manufacturing: From Wood Pulp to Pharmaceutical Powder

Microcrystalline cellulose is obtained from wood pulp (or other α-cellulose-grade plant fibers). The process relies on controlled acid hydrolysis: a dilute mineral acid selectively attacks the amorphous regions of the cellulose fibers, while the more resistant crystalline regions remain intact.

This yields a so-called 'hydrocellulose' made up of microcrystals, which is then neutralized, washed, and spray-dried into a fine, free-flowing powder. The resulting degree of polymerization is markedly lower than that of the starting cellulose, which gives the product its specific properties.

Physicochemical Properties and Grades

MCC is chemically inert, physiologically harmless, and non-allergenic. It stands out for its excellent compressibility: under pressure, its particles deform plastically and form numerous interparticle bonds, producing hard, cohesive tablets even at low compression forces.

It also offers good flow properties (particularly in granular grades) and a water-absorption capacity that promotes tablet disintegration. It is available in several standardized grades (PH-101, PH-102, PH-200, PH-112, and others) differing in particle size, density, and moisture content. These variants explain the many microcrystalline cellulose references found in a raw-material catalog.

Use in Pharmaceutical Formulation

Microcrystalline cellulose fulfills several essential functions in the formulation of solid oral dosage forms:

It is precisely thanks to excipients such as MCC that poorly compressible active ingredients like paracetamol can be turned into tablets with good hardness and stability.

Learn more

Disclaimer — This document is provided for informational and documentary purposes only. It does not replace official pharmacopoeia monographs or medical or pharmaceutical advice.

← Back to Excipients